Numab Therapeutics AG
Weitere Informationen finden Sie unter www.numab.com.
Numab Therapeutics AG
Founded in 2011, Numab develops a proprietary pipeline of multi-specific biotherapeutics in immuno-oncology and immunology, and has a number of discovery partnerships with pharmaceutical companies. Numab’s plug-and-play multi-specifics platform allows for a highly rational and reproducible process that rapidly yields promising clinical candidates with new mechanisms of action, superior efficacy and a favorable safety profile.
For further information, visit www.numab.com.
Kontakt
Numab Therapeutics AG
Einsiedlerstrasse 34
CH-8820 Wädenswil
www.numab.com
Dr. David Urech
CEO und CSO
Dr. Oliver Middendorp
CBO